Behavioral Health Psychotropics

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC53-3

DiraChart Clinical Reference
Protected section 3 of 15
← Document menu
Nursing Home · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 3 of 15PreviousNext

2. What to assess, technique, and required data

Document behaviors and the pharmacologic/non-pharmacologic response over time:

  • Target behaviors with frequency, intensity, and triggers (behavior monitoring), and the non-pharmacologic interventions tried and their effect.
  • For each psychotropic: the documented indication and diagnosis, the target symptoms, the monitoring parameters, and consent.
  • GDR attempts and outcomes, or the documented clinical contraindication to reducing; PRN psychotropic use against the time limits.

MDS-supportive data

Psychotropic medication days (antipsychotic, antianxiety, antidepressant, hypnotic) are coded in MDS Section N; behaviors in Section E; mood (PHQ) in Section D; cognition (BIMS) in Section C. The record must support each — the behavior data and the medication indication must be findable (F641, and the antipsychotic quality measure).

Section NavigationPart 3 of 15PreviousNext